Results 121 to 130 of about 9,378,676 (283)

Vaccination strategies for the prevention of meningococcal disease

Human Vaccines & Immunotherapeutics, 2018
Routine prophylactic vaccination and mass vaccination strategies have been used to control both endemic and epidemic disease caused by Neisseria meningitidis globally.
S. Vuocolo, P. Balmer, W. Gruber, K. Jansen, A. Anderson, John L. Perez, L. York   +6 more
semanticscholar   +1 more source

Meningococcal Disease

Journal of the Ceylon College of Physicians
Meningococcal disease, caused by Neisseria meningitidis, is a rapidly progressive, potentially life-threatening infection. The organism, an encapsu-lated Gram-negative diplococcus, is classified into at least 13 serogroups, with A, B, C, W, X, and Y being responsible for most invasive cases.
  +4 more sources

Event-based surveillance during EXPO Milan 2015. Rationale, tools, procedures, and initial results [PDF]

, 2016
More than 21 million participants attended EXPO Milan from May to October 2015, making it one of the largest protracted mass gathering events in Europe.
Bastiampillai, Anan Judina, Caporali, Maria Grazia, Costanzo, Virgilio, Declich, Silvia, Gabrielli, Eugenia, Gramegna, Maria, Linge, Jens P., Manso, Martina Del, Mantica, Eleonora, Napoli, Christian, Piatti, Alessandra, Pompa, Maria Grazia, Riccardo, Flavia, Vellucci, Loredana, Verile, Marco   +14 more
core   +1 more source

AMEND study protocol: a case–control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults

BMJ Open, 2019
Introduction Invasive meningococcal disease (IMD) primarily causes disease in young children and adolescents and can cause long-term disability. Many countries are considering implementation of meningococcal B and/or meningococcal ACWY vaccines to ...
David Gordon, Helen Marshall, Mark McMillan, Peter Richmond, Christopher C Blyth, Jim Buttery, David Shaw, Belinda Barton, Bing Wang, Robert Booy, Hossein Afzali   +10 more
doaj   +1 more source

Validation of the Vaccination Confidence Scale: A Brief Measure to Identify Parents at Risk for Refusing Adolescent Vaccines [PDF]

, 2016
Objective To validate a brief measure of vaccination confidence using a large, nationally representative sample of parents. Methods We analyzed weighted data from 9018 parents who completed the 2010 National Immunization Survey–Teen, an annual ...
Brewer, Joseph M., Dempsey, Amanda F., Gilkey, Melissa, Magnus, Brooke E., McRee, Annie-Laurie, Reiter, Paul   +5 more
core   +3 more sources

Meningococcal Disease Surveillance in Men Who Have Sex with Men — United States, 2015–2016

MMWR. Morbidity and mortality weekly report, 2018
Meningococcal disease is a rare, but serious, bacterial infection that progresses rapidly and can be life-threatening, even with prompt antibiotic treatment.
C. Bozio, Amy E. Blain, Jessica R Macneil, Adam C. Retchless, Lauren M. Weil, Xin Wang, Laurel T Jenkins, L. Rodriguez-Rivera, Claire Jarashow, Van P Ngo, S. Hariri, Sarah A Mbaeyi, Sara E. Oliver   +12 more
semanticscholar   +1 more source

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016

Emerging Infectious Diseases, 2017
During the first 12 months of an emergency meningococcal ACWY vaccination program for teenagers in England, coverage among persons who left school in 2015, the first cohort to be vaccinated, was 36.6%.
H. Campbell, M. Edelstein, N. Andrews, R. Borrow, M. Ramsay, S. Ladhani   +5 more
semanticscholar   +1 more source

Societal costs due to meningococcal disease: a national registry-based study

ClinicoEconomics and Outcomes Research, 2018
Nina Gustafsson,1 Sandra Elkjær Stallknecht,1 Mette Skovdal,2 Peter Bo Poulsen,3 Lars Østergaard4 1Incentive, Holte, Denmark; 2Vaccines, Pfizer Denmark, Ballerup, Denmark; 3Health and Value, Pfizer Denmark, Ballerup, Denmark; 4Department of ...
Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L   +4 more
doaj  

Safety and efficacy of eculizumab in adult and pediatric patients with aHUS, with or without baseline dialysis [PDF]

, 2015
C
Hourmant, Maryvonne, Kincaid, John F, Legendre, Christophe M, Menne, Jan, van de Kar, Nicole CAJ, Vande Walle, Johan   +5 more
core   +1 more source

Recent Progress in the Prevention of Serogroup B Meningococcal Disease

Clinical and Vaccine Immunology, 2017
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge of providing protection against serogroup B disease.
I. Feavers, M. Maiden
semanticscholar   +1 more source